Protection from moisture is particularly critical for orally disintegrating tablets, as these formulations are designed to rapidly absorb moisture and dissolve
Scenario 2: Cardiovascular Disease or High Risk Consider a 60-year-old patient with established coronary artery disease
Improving insulin resistance with GLP-1 drugs turns out to be beneficial not just for obesity and diabetes, but also for the prevention of pancreatitis and non-alcoholic fatty liver disease
This might involve working with insurance companies, governments, and healthcare providers to make the treatment affordable and widely available
In the future, GLP-1RAs and co-agonists may serve as supplements for personalized therapies targeting metabolic control, anti-inflammation, and even anti-fibrosis effects
However, unlike these other options, Rybelsus is taken orally rather than by injection